TUCSON, Ariz. (AP) _ Accelerate Diagnostics Inc. (AXDX) on Monday reported a loss of $23.2 million in its second quarter.
The Tucson, Arizona-based company said it had a loss of 43 cents per share.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 37 cents per share.
The maker of systems that diagnose drug-resistant infections posted revenue of $1.7 million in the period, which also missed Street forecasts. Three analysts surveyed by Zacks expected $2.2 million.
Accelerate Diagnostics shares have dropped 17 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $21.75, a decrease of 14 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXDX at https://www.zacks.com/ap/AXDX